Can I Take Saw Palmetto with Vyleesi (Bremelanotide)?
HealthRX.com
No study has tested saw palmetto with Vyleesi directly
Key numbers
- 1.75 mgVyleesi dose per injection, given at least 45 minutes before sexual activitySource: dailymed.nlm.nih.gov, as cited Nov 7, 2026
- 40.0%Nausea on Vyleesi vs placebo in pooled phase 3 trialsSource: dailymed.nlm.nih.gov, as cited Nov 7, 2026
- 13.2%Injection site reactions on Vyleesi vs placebo in pooled phase 3 trialsSource: dailymed.nlm.nih.gov, as cited Nov 7, 2026
- 6 mmHgMaximal transient rise in systolic blood pressure after one Vyleesi doseSource: dailymed.nlm.nih.gov, as cited Nov 7, 2026
- 5.4%Serious adverse events in saw palmetto group in the 225-man STEP trialSource: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026
At a glance
- Drug / Vyleesi (bremelanotide) 1.75 mg subcutaneous autoinjector, used as needed [1]
- Supplement / Saw palmetto (Serenoa repens) berry extract, sold as a dietary supplement [4]
- Interaction studies with saw palmetto / None described in the Vyleesi label [1]
- Label interaction advice / Vyleesi may slow gastric emptying and reduce absorption of oral medicines; oral naltrexone is named [1]
- Vyleesi common effects / Nausea 40.0%, flushing 20.3%, injection site reactions 13.2%, vs placebo 1.3%, 0.3%, 8.4% [1]
- Pregnancy / Label advises stopping Vyleesi if pregnancy is suspected and using effective contraception [1]
What Vyleesi Is and What Its Label Covers
Vyleesi is bremelanotide, an FDA-approved subcutaneous autoinjector for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD) [1]. The dose is 1.75 mg injected into the abdomen or thigh at least 45 minutes before anticipated sexual activity, no more than once in 24 hours, and more than 8 doses a month is not recommended [1]. It is not indicated for HSDD in postmenopausal women or in men, and not to enhance sexual performance [1].
Does Saw Palmetto Interact with Vyleesi?
No study has tested saw palmetto with Vyleesi. The label does not list saw palmetto among interacting products [1]. A 2017 review of common herbal interactions places saw palmetto among supplements with a low likelihood of drug interactions that can, with certain caveats, be taken with most medicines [6], and a 2009 systematic review of herbal-drug interactions reported no interactions for saw palmetto [7]. Both reviews were published before bremelanotide's 2019 approval [8].
The label describes bremelanotide as metabolized by hydrolysis of amide bonds, with 64.8% of radioactivity recovered in urine and 22.8% in feces after a 1.75 mg subcutaneous dose; mean peak plasma level was 72.8 ng/mL, median time to peak about 1.0 hour, and mean terminal half-life about 2.7 hours [1].
What the Label Says About Other Oral Products
The label says Vyleesi may slow gastric emptying and thus has the potential to reduce the rate and extent of absorption of oral medicines taken with it [1]. It advises avoiding oral drugs that depend on threshold concentrations for efficacy, such as some antibiotics, and considering skipping a dose if a quick effect from an oral medicine is wanted, giving indomethacin as the example [1]. The label specifically says to avoid oral naltrexone-containing products used for alcohol or opioid addiction. In clinical pharmacology studies only naltrexone and indomethacin were meaningfully affected [1].
The label does not say whether this warning applies to oral supplements such as saw palmetto [1].
Bleeding and Injection-Site Reactions
Injection site reactions were reported by 13.2% of Vyleesi patients versus 8.4% on placebo in the pooled phase 3 trials, a category that includes pain, redness, hematoma, itching, hemorrhage, bruising, tingling and reduced sensation [1].
Saw palmetto's bleeding record is thin and mixed. One case report described severe bleeding during an operation in a man taking saw palmetto, with a prolonged bleeding time that returned to normal a few days after he stopped the herb [2]. Against that, 75 men scheduled for prostate surgery were randomized to a control group (21 men), dutasteride 5 mg daily (27) or saw palmetto 160 mg daily (27) for 5 weeks; total blood loss, blood loss adjusted for time and tissue removed, hemoglobin change and microvessel density did not differ significantly between groups [3]. NCCIH describes saw palmetto as well tolerated, with mild and infrequent side effects including digestive symptoms, dizziness and headache [4].
Side Effects Each Product Can Cause
In the pooled phase 3 trials (1,247 premenopausal women: 627 on Vyleesi, 620 on placebo), the reported rates on Vyleesi versus placebo were nausea 40.0% vs 1.3%, flushing 20.3% vs 0.3%, injection site reactions 13.2% vs 8.4%, headache 11.3% vs 1.9% and vomiting 4.8% vs 0.2% [1]. Nausea was highest after the first dose, reported by 21% of patients, then fell to about 3% with later doses; 13% used an anti-nausea medicine and 8% stopped the trials because of nausea [1]. In a phase 4 study of 228 healthy women, ondansetron 8 mg taken 30 minutes before a Vyleesi dose did not reduce nausea, and the label states that pre-treatment with oral ondansetron is not recommended [1].
NCCIH lists digestive symptoms, dizziness and headache as saw palmetto's mild, infrequent side effects [4]. In the 225-man STEP trial, at least one serious adverse event occurred in 5.4% of the saw palmetto group versus 9.7% of the placebo group (p=0.31) [10].
Label Cautions That Apply Whatever Else You Take
Vyleesi is contraindicated in patients with uncontrolled hypertension or known cardiovascular disease, and the label says it is not recommended for patients at high risk for cardiovascular disease [1]. Each dose raises blood pressure transiently: maximal increases of 6 mmHg systolic and 3 mmHg diastolic, peaking 2 to 4 hours after the dose, with heart rate down up to 5 beats per minute and values usually back to baseline within 12 hours [1]. In an 8-day ambulatory study of 127 premenopausal women dosed once daily, mean daytime blood pressure rose 1.9 mmHg systolic and 1.7 mmHg diastolic [1].
The label advises discontinuing Vyleesi if pregnancy is suspected and using effective contraception; in dogs, fetal harm occurred at exposures at least 16 times the human dose based on AUC [1]. FDA approved a labeling supplement on October 22, 2026 that updates the pregnancy section and the patient information [12]. NCCIH says saw palmetto may be unsafe during pregnancy or while breastfeeding [4].
Check what you know
Question 1 of 3
Score: 0 right, 0 of 3 answered
Questions worth asking
Frequently asked questions
Can you take saw palmetto with Vyleesi?
Could saw palmetto affect how Vyleesi is absorbed?
Do Vyleesi injection site reactions include bleeding or bruising?
Is saw palmetto safe to take long term?
Can men take saw palmetto with bremelanotide?
References
Show all 12 referencesHide references
- U.S. National Library of Medicine, DailyMed. Vyleesi (bremelanotide) injection, 1.75 mg subcutaneous autoinjector prescribing information. Vyleesi (bremelanotide) injection, 1.75 mg subcutaneous autoinjector label
- Cheema P, El-Mefty O, Jazieh AR. Intraoperative haemorrhage associated with the use of extract of Saw Palmetto herb: a case report and review of literature. J Intern Med. 2001;250(2):167-9.
- Tuncel A, Ener K, Han O, Nalcacioglu V, Aydin O, Seckin S, et al. Effects of short-term dutasteride and Serenoa repens on perioperative bleeding and microvessel density in patients undergoing transurethral resection of the prostate. Scand J Urol Nephrol. 2009;43(5):377-82.
- Saw Palmetto: Usefulness and Safety | NCCIH.
- Strauch G, Perles P, Vergult G, Gabriel M, Gibelin B, Cummings S, et al. Comparison of finasteride (Proscar) and Serenoa repens (Permixon) in the inhibition of 5-alpha reductase in healthy male volunteers. Eur Urol. 1994;26(3):247-52.
- Asher GN, Corbett AH, Hawke RL. Common Herbal Dietary Supplement-Drug Interactions. Am Fam Physician. 2017;96(2):101-107.
- Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: an updated systematic review. Drugs. 2009;69(13):1777-98.
- U.S. Food and Drug Administration.
- Marks LS, Hess DL, Dorey FJ, Luz Macairan M, Cruz Santos PB, Tyler VE. Tissue effects of saw palmetto and finasteride: use of biopsy cores for in situ quantification of prostatic androgens. Urology. 2001;57(5):999-1005.
- Avins AL, Bent S, Staccone S, Badua E, Padula A, Goldberg H, et al. A detailed safety assessment of a saw palmetto extract. Complement Ther Med. 2008;16(3):147-54.
- Franco JV, Trivisonno L, Sgarbossa NJ, Alvez GA, Fieiras C, Escobar Liquitay CM, et al. Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement. Cochrane Database Syst Rev. 2023;6(6):CD001423.
- U.S. Food and Drug Administration. Approval letter for NDA 210557 labeling supplement S-005, 2026.